Alexander KarpAlexander Karp earned $1B in 2024

In 2022, Anthony G. Quinn earned $1.61M in total compensation at Spyre Therapeutics, Inc., primarily from $424.43K salary. Led Spyre Therapeutics, Inc. as CEO for 5 years.

Compensation History

Annual executive compensation data for Anthony G. Quinn, including salary, bonuses, and stock awards.

Year

2022

Total Compensation

$1.61M

Salary

$424.43K

Bonus

$0.00

Other

$1.19M

Salary

$424.43K

Board Justification

Our compensation committee has historically determined our executive compensation and determines the compensation of our Named Executive Officers. Our compensation committee typically reviews and discusses management’s proposed compensation with the Chief Executive Officer for all executives other than the Chief Executive Officer. Based on those discussions and its discretion, our compensation committee then approves the compensation of each executive officer after discussions without members of management present.

Bonus

$0.00

Board Justification

Cash bonuses earned in 2022 and paid in 2023, based in part on achievement of specified milestones and performance objectives.

Other Compensation

$1.19M

Board Justification

Includes severance payment of $1,176,000 in connection with Dr. Quinn’s termination of employment and matching 401(k) or other retirement plan contributions paid by us on their behalf in the amount of $12,200.

Restricted Stock

$0.000 N/A

Board Justification

N/A

Performance Metrics

Cash bonuses earned in 2022 and paid in 2023, based in part on achievement of specified milestones and performance objectives.

S

Anthony G. Quinn

Ex-CEO of Spyre Therapeutics, Inc.

Education

B.MSc in General Pathology, M.B Ch.B in Medicine from the University of Dundee, Ph.D. in Cancer Research from the University of Newcastle upon Tyne.

Field of Expertise

Healthcare & Life Sciences - Medicine

Sector of Economy

Healthcare

CEO of Spyre Therapeutics, Inc. for

5 years 1 month (Jul 2017 - Aug 2022)

Previous Experience

Head of Research & Development and Chief Medical Officer at Synageva BioPharma Corp.

Holdings

Track Anthony G. Quinn's stock holdings and portfolio value over time.

Insider Trading

Anthony G. Quinn's recent stock transactions, purchases, and sales filed with the SEC.

No insider trades found for this CEO.

Rivals

Compare Anthony G. Quinn with competitor CEOs and industry peers.